Immediate Impact

1 by Nobel laureates 1 from Science/Nature 61 standout
Sub-graph 1 of 21

Citing Papers

Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
2023 Standout
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout
2 intermediate papers

Works of Shūichi Katoh being referenced

Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction
2005

Author Peers

Author Last Decade Papers Cites
Shūichi Katoh 216 95 125 12 427
Christos Kalofoutis 170 105 85 17 491
Miho Senda 203 95 60 17 461
P Gasparini 265 106 149 10 450
Miyoko Komatsu 156 111 128 9 445
Rieko Hayaishi-Okano 245 66 160 8 490
Elvira Castro-Quintela 138 79 88 11 380
Linlin Mai 284 112 164 7 504
A. S. Krolewski 325 55 121 11 494
Vassen Pauvaday 258 103 90 14 470
P R Conlin 126 62 182 8 405

All Works

Loading papers...

Rankless by CCL
2026